Join Sean Macfarlane, Founder and CEO of Biomarx, for a raw look at the transition from academic research to high-stakes biotech entrepreneurship. A molecular and cellular biologist with a background in infectious diseases and automated platforms, Sean pivoted to tackle one of the most pressing challenges in medicine: lung cancer. In this episode, we explore the "why" and "how" of launching a startup before the MVP exists—navigating IP complications, securing pre-seed funding as a first-time founder, and leveraging the rapidly growing Irish tech ecosystem.

🎯 Insights You’ll Learn:

✓ The Pivot: Why IP and funding hurdles turned an academic project into a commercial startup

✓ Raising on Vision: How to secure pre-seed investment with no MVP and no data

✓ The Northern Ireland Advantage: Leveraging the Clarendon Co-Fund and In ...